Accuray Incorporated (NASDAQ:ARAY) Sellers Decreased Their Shorts By 25.45% As Of May 16, 2018

May 16, 2018 - By Theresa Judd

Accuray Incorporated (NASDAQ:ARAY) Corporate Logo

During 2017 Q4 the big money sentiment decreased to 1.07. That’s change of 0.16, from 2017Q3’s 1.23. 13 investors sold all, 31 reduced holdings as Accuray Incorporated ratio dropped. 29 increased positions while 18 funds took positions. Funds hold 64.52 million shares thus 1.17% more from 2017Q3’s 63.77 million shares.
Engineers Gate Manager Limited Partnership has invested 0.01% in Accuray Incorporated (NASDAQ:ARAY). 20,050 were reported by Thompson Davis Com. Ameritas Invest Ptnrs reported 6,420 shs. Parametric Port Assoc Limited Liability reported 51,013 shs. 639,254 were reported by Bankshares Of Mellon Corp. Millennium Mngmt Ltd Liability Company has invested 0.02% in Accuray Incorporated (NASDAQ:ARAY). Gp One Trading Lp holds 0% in Accuray Incorporated (NASDAQ:ARAY) or 4,192 shs. 16,920 are owned by Natl Bank Of Montreal Can. Ubs Asset Americas reported 0% stake. Us Bancshares De has 997 shs. Mufg Americas accumulated 256 shs or 0% of the stock. 14,427 were reported by Tudor Inv Et Al. Vanguard Group owns 0% invested in Accuray Incorporated (NASDAQ:ARAY) for 6.50M shs. Invesco Limited reported 47,192 shs. D E Shaw & Inc has invested 0.01% of its capital in Accuray Incorporated (NASDAQ:ARAY).

Accuray Incorporated had 3 sales and 0 buys since April 3, 2018. This’s net activity of $66,295. Another trade for 2,585 shs valued at $12,020 was made by Nouri Alaleh on Tuesday, April 3. $13,936 worth of Accuray Incorporated (NASDAQ:ARAY) shs were sold by Waters Kevin.

Change of 25.45% for Accuray Incorporated (NASDAQ:ARAY)’s shorted shares was recorded. FINRA announced in May ARAY’s total 3.61 million shorted shares. Previously was reported down change of 25.45% from 4.84M shares. 9 days will cost ARAY with 388,900 average volume to recover its previous position. Accuray Incorporated float short is 4.63%.

ARAY is hitting $4.85 during the last trading session, after increased 3.19%.Currently Accuray Incorporated is uptrending after 2.08% change in last May 16, 2017. ARAY has 141,174 shares volume. ARAY underperformed by 9.47% the S&P500.

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body.The company has $415.35 million market cap. The firm offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body.Currently it has negative earnings. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally.

Accuray Incorporated (NASDAQ:ARAY) Ratings Coverage

In total 5 analysts cover Accuray (NASDAQ:ARAY). “Buy” rating has 2, “Sell” are 2, while 1 are “Hold”. (NASDAQ:ARAY) has 40% bullish analysts. 5 are the (NASDAQ:ARAY)’s ratings reports on May 16, 2018 according to StockzIntelligence Inc. On Tuesday, January 23 the firm has “Buy” rating given by Jefferies. The stock rating was maintained by RBC Capital Markets with “Hold” on Wednesday, January 24. On Wednesday, December 13 the stock of Accuray Incorporated (NASDAQ:ARAY) has “Underweight” rating given by JP Morgan. In Wednesday, December 13 report J.P. Morgan downgraded the stock to “Sell” rating.

Another two news for Accuray Incorporated (NASDAQ:ARAY) were briefly posted by: on May 04, 2018 with title “Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules”. The other‘s article was titled “Factors of Influence in 2018, Key Indicators and Opportunity within Accuray, Torchmark, Carlisle Companies, CVR …” and posted on May 15, 2018.

Accuray Incorporated (NASDAQ:ARAY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.